SGR ASX: Bruce Mathieson buys more Star shares as inquiry fallout spreads
The independent inquiry into the casino group heard from more current and former executives about dysfunction within the business.
Source: afr.com
📰 Peter Widdows News
Peter Widdows News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Peter Widdows. Real-time updates on events, politics, business and more.
Clarion Clinics Received Ethics Board Endorsement For MDMA & Psilocybin Administration - Incannex Healthcare (NASDAQ:IXHL)
Melbourne will soon open Clarion Clinics’ first exclusively dedicated facility to provide psychedelic-assisted therapies legalized in Australia. 
Joel Latham Peter Widdows Australian Therapeutic Goods Administration Human Research Ethics Committee Clarion Clinic Incannex Healthcare
Source: benzinga.com
Breaking Boundaries: Medical Psychedelics
Australia is the first country in the world to legalise the use of psychedelic drugs for mental illness
Source: fnarena.com
Psychedelic therapy access still some time off in SA
Despite magic mushrooms and MDMA becoming prescribable, those in SA desperate for psychedelic therapy access have no choice but to wait.
South Australia Peter Widdows Therapeutic Goods Administration Terms Of Service Clarion Clinics Group Authorised Prescriber Scheme
Source: indaily.com.au
Incannex Healthcare's Clarion Clinics accepting registrations for psychedelic-assisted therapy treatment
Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) subsidiary Clarion Clinics Group Pty Ltd has begun accepting registrations of interest in...
New South Wales Paul Liknaitzky Peter Widdows Suresh Sundram Sean Ocarroll Clarion Clinics Group Pty Ltd
Source: proactiveinvestors.com.au
Incannex Healthcare : Clarion Clinics Begins Accepting Registrations for Psychedelic Treatment Interest as Part of Pre-Screening in Readiness for Opening
Clarion Clinics Begins Accepting Registrations for Psychedelic Treatment Interest as Part of Pre-Screening in Readiness for Opening Highlights: ...
Source: marketscreener.com
Incannex Healthcare June 2023 Quarterly Activities Report and Appendix 4C Cash Flow Statement
28.07.2023 - MELBOURNE, Australia, July 28, 2023 (GLOBE NEWSWIRE) - Clinical stage pharmaceutical development company, Incannex Healthcare Limited (ASX: IHL) (NASDAQ: IXHL), (‘Incannex’ or the ‘Company’), is pleased to provide its quarterly activities report ...
Source: wallstreet-online.de
Treating depression, PTSD with psychedelics such as psilocybin, MDMA and ketamine won't be cheap
Authorised psychiatrists will be able to prescribe psychedelics to eligible patients as of July 1, but the path ahead is far from straightforward.
Source: afr.com
Australian health insurers and pharmaceutical companies reckon with new psychedelic mental health treatments
While very few patients are expected to access new psychedelic therapies when regulatory changes take effect next month, medicinal cannabis companies, drug developers and health insurers are keeping watch on the emerging industry.
Source: abc.net.au
Incannex Healthcare Ltd welcomes world-leading psychedelics experts to advisory board
Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) director Peter Widdows tells Proactive the company has appointed three world-renowned psychedelic therapy and...
Paul Liknaitzky Peter Widdows Suresh Sundram Sean Ocarroll Incannex Healthcare Ltd Clarion Clinics Group Advisory Board
Source: proactiveinvestors.com